Abstract
Diabetes and hypertension were the most common comorbidities among COVID-19 deaths, at 20.45% and 17.42% respectively in Mali. The aim of this study was to analyze the clinical and biological aspects of COVID-19 and diabetes in Mali from 2020 to 2023. The present study constitutes a comparative cross-sectional analytical study that included 50 patients. Data were collected at home, in the form of individual interviews with patients. Findings indicate before the pandemic, 34% of patients were obese and 54% had uncontrolled diabetes. Arterial hypertension was the only macro-angiopathic complication found in patients, with an increase in frequency during the pandemic whereas respiratory distress was observed in 25% of patients during COVID-19 infection. This means that COVID-19 is as much a risk factor associated with diabetes as diabetes is a factor affecting patients' health.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
